Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Concerned Shareholders of Sernova Corp. Stand by their Statements

T.SVA

TORONTO, April 17, 2023 /CNW/ - The group of longstanding shareholders (the "Concerned Shareholders") of Sernova Corp (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH) (XETRA: PSH) ("Sernova" or the "Company") maintains that the decrease in share valuation, lack of investor updates and progress relating to clinical studies, deficiencies relating to business development and partnerships, unjustified compensation as well as corporate governance issues have not been addressed by the current board of directors, nor by the current management team.

Our primary objective remains giving shareholders the opportunity to elect two representative directors to the board, with an emphasis on positive and constructive contributions to unlock value and improve Sernova's ability to maintain timelines, meet key milestones and create meaningful and sustainable shareholder value.

We see short term opportunities to monetize Sernova's accomplishments, thus positioning it as an independent, viable company with renewed relevance in the capital markets.

We also need to ensure that Sernova's lead position in the race to cure different applications is not eroded. There is urgency in recognizing that Sernova's competition continue with their research and trials.

Regarding compensation, we strongly believe that the increases recommended by Sernova are unreasonable, unjustified, not supported by company progress or metrics and unwarranted in a context where Sernova does not yet generate revenue. Below is the compensation table taken directly and integrally from Sernova management's circular that demonstrates the explosion in the compensation amounts over the past two years.
 

Name and Principal Position

Year

Salary ($)

Share based awards ($)

Option based awards ($) (1)

Non-equity incentive plan compensation

All other compensation ($)(5)

Total compensation ($)

Annual incentive plan

Long-term incentive plan

Frank Holler(5)

Executive Chair

2022

2021

2020

-

-

-

495,000

-

-

350,000

-

-

-

-

-

-

-

-

67,750

66,188

37,792

912,750

66,188

37,792

Dr. Philip M. Toleikis
President & CEO

 

2022

2021

2020

456,000

409,750

315,000

-

-

-

4,859,668

-

-

262,200

224,250

52,500

-

-

-

-

-

-

5,577,868

634,000

367,500

David Swallow CFO

2022

2021

2020

268,000

240,188

183,750

-

-

-

2,893,864

-

-

123,280

104,650

-

-

-

-

-

-

3,285,144

344,838

183,750

Frank Shannon(2)  VP,
Clinical Development
and Regulatory Affairs

2022

2021

2020

250,000

60,737

-

 

-

-

-

315,300

-

-

71,000

-

-

-

-

-

-

-

-

636,300

60,737

-

Chris Barnes(3) VP,
Investor Relations

2022

2021

2020

142,083

-

-

-

-

-

189,180

-

-

8,138

-

-

-

-

-

-

-

-

339,401

-

-

It is to be noted that besides the management circular, there is not a single independent recommendation in favor of the compensation resolution.

Long standing shareholders who have helped promote Sernova's potential to their family, friends and associates in the past years are mostly supportive of the Concerned Shareholder Group's initiative to effect unquestionably needed change. These long-standing shareholders have been front row witnesses to Sernova's historical and documented episodes of missed deadlines, unmet commitments, and difficulties in defining and executing a business plan.

Conversely, we understand that those who have only recently been exposed to the company may lack this historical context. Whether shareholders or analysts, without this context, it can be difficult to challenge current management's assertions and identify repetitions or inconsistencies with passed promises.

We urge all shareholders to vote according to the Gold Proxy to ensure:

  • Two board members represent shareholder interests (Dr. Steven Sangha, Mr. Bertram von Plettenberg);
  • Unequivocal rejection of the unjustified and unreasonable compensation resolution;
  • A coherent business plan is defined, communicated, implemented and for which progress will be measured;
  • Implementation of commercial initiatives to monetize Sernova's accomplishments;
  • Past and unexplained delays are not repeated; and
  • Sernova's market and industry reputations are restored, and strategic partnerships be put in place.

We look forward to working with the board members and management following this election to monetize everyone's investment and ensure Sernova remains in a leadership position… to the benefit of all shareholders.

The deadline to vote is fast approaching.

Please vote by April 24, 2023 to ensure that your vote is counted! If you have any questions or requires assistance with voting, please contact Carson Proxy Advisors at North American toll free phone at 1-800-530-5189, local (collect outside North America) 416-751-2066 or by email at info@carsonproxy.com.

Advisors

Kushneryk Morgan LLP is serving as legal advisor to Dr. Sangha and Stephan Dubreuil and Carson Proxy Advisors is acting as strategic shareholder communications advisor to the Concerned Shareholders.

Cautionary Statement Regarding Forward-Looking Information

Certain information included, attached to, provided with, or incorporated by reference into this release may contain forward-looking statements, as such term is defined and/or used in applicable Canadian securities legislation, about the objectives of the Concerned Shareholders as they relate to Sernova, the impact of the Concerned Shareholders Nominees, if elected, on the financial condition, results of operations, business strategies, revenue enhancements, and competitive position of Sernova, each as described in this release, and other matters.

All statements included or incorporated by reference in, attached to, or provided with this release, other than statements of historical fact, are forward-looking statements, including, without limitation, statements regarding activities, events or developments that the Concerned Shareholders expect or anticipate may occur in the future. These forward-looking statements can be identified by the use of forward-looking words such as "possibly", "will", "expect", "intend", "plan", "estimate", "potential", "anticipate", "believe" or "continue" or similar words or the negative thereof and include statements concerning support for the Concerned Shareholders, the implementation and timing of the Corporation's business strategy, the plans and intentions for the future by the Concerned Shareholders Nominees, the role for members of current management and the search for new members of management, transition plans, financing arrangements and the future market for and liquidity of the Corporation's shares.

The forward-looking statements included in this release are based on understandings and reasonable assumptions, beliefs, opinions and expectations of the Concerned Shareholders at the time they are made. These assumptions include, but are not limited to, Sernova's future growth potential; its results of operations; future cash flows; the future performance and business prospects and opportunities of Sernova; the election of the Concerned Shareholders Nominees; the ability of the Concerned Shareholders Nominees, if elected, to effect positive change at Sernova and appoint other individuals as directors; the response to and outcome of any court applications that may be made against the Concerned Shareholders; the implementation and timing of Sernova's business strategy; the current general and regulatory environment and economic conditions remaining unchanged; the availability of financing; operating and capital costs; Sernova's available cash resources; Sernova's ability to identify, attract and retain skilled staff, including a new Chief Executive Officer; currency exchange rates; required capital investments; estimates of net present value and internal rate of returns; market competition; ongoing relations with employees and other stakeholders in the gaming community; and general business and economic conditions.

There can be no assurance that the plans, intentions or expectations upon which these forward-looking statements are based will occur. We caution readers of this release not to place undue reliance on forward looking statements contained in this release, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors include shareholder actions, court decisions, the timing of the Meeting, actions by the Corporation, its management, members of the Current Board, unexpected change of control consequences, the failure of shareholders to nominate the Concerned Shareholders Nominees, the status of Sernova's assets, financial condition and corporate books and records, general economic and market conditions, availability of capital, changes in law, regulatory processes, actions of competitors, and the ability to implement business strategies and pursue business opportunities and financing alternatives after a state of uncertainty. Holders of Common Shares in the capital of the Corporation are cautioned that all forward-looking statements involve risks and uncertainties, including those risks and uncertainties detailed in Sernova's filings with applicable Canadian securities commissions, copies of which are available under Sernova's issuer profile at www.sedar.com. We urge you to carefully consider those factors. The forward-looking statements contained in this release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements included in this release are made as of the date of this release and the Concerned Shareholders undertake no obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise, except as required by law.

SOURCE The Group of Shareholders of Sernova Corporation

 

Cision View original content: http://www.newswire.ca/en/releases/archive/April2023/17/c7450.html




Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today